Below, I'll break down what's going on at Viking and explain how the company may emerge as a competitive force in the weight ...

Esperion Therapeutics' aggressive commercialization efforts have significantly boosted retail prescriptions and broadened ...

Tempest Therapeutics (TPST – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst ...

Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Good afternoon, and thank you for standing by. At this time, I’d ...

H.C. Wainwright analyst Douglas Tsao reiterated a Buy rating on Xenon (XENE – Research Report) today and set a price target of $53.00.

Recent developments driving growth in this area make the advanced, AI-supported digitization of pharma pipelines inevitable.

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

The program taps into several OpenAI models and can be used across a wide range of therapeutic indications. Both Big Pharma ...

Acadia Pharmaceuticals sold its priority review voucher for $150 million. Haleon named Vistar Media, a location-based ad ...

Negative data cost AbbVie billions of dollars in market value and convinced analysts Bristol Myers had placed a better bet in ...

Many patients with IBD report persisting symptoms, despite resolution of the inflammatory process. Although by definition, a ...